Ming‐Chung Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
Papers in
- Oncology 22
- Viral-associated cancers and disorders 9
- Hematology 17
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Ching‐Yuan Kuo (10 shared papers)Ming‐Chun Ma (13 shared papers)Sung‐Nan Pei (9 shared papers)Chien‐Hung Chen (3 shared papers)Chuan–Mo Lee (1 shared paper)Tsung‐Hui Hu (1 shared paper)Wan‐Ting Huang (6 shared papers)Huey‐Ling You (5 shared papers)
- Journals
- Blood (8 papers)Clinical Biochemistry (3 papers)Experimental and Molecular Pathology (2 papers)Fluid Phase Equilibria (2 papers)Annals of Hematology (2 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ming‐Chung Wang
44 papers receiving 573 citations
Peers
Comparison fields: 5 of 86
- Hepatology 194
- Hematology 124
- Epidemiology 218
- Oncology 164
- Genetics 63
Countries citing papers authored by Ming‐Chung Wang
This map shows the geographic impact of Ming‐Chung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chung Wang more than expected).
Fields of papers citing papers by Ming‐Chung Wang
This network shows the impact of papers produced by Ming‐Chung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chung Wang. The network helps show where Ming‐Chung Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Chung Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 160 | |
| 2 | 2012 | 73 | |
| 3 | Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. | 2006 | 44 |
| 4 | 2023 | 36 | |
| 5 | 1973 | 30 | |
| 6 | 2014 | 28 | |
| 7 | 2018 | 21 | |
| 8 | Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. | 2014 | 19 |
| 9 | 2009 | 17 | |
| 10 | Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature. | 2013 | 14 |
| 11 | 2010 | 12 | |
| 12 | 2013 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2010 | 10 | |
| 16 | 2004 | 9 | |
| 17 | 2019 | 8 | |
| 18 | 2015 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2000 | 6 |
About Ming‐Chung Wang
Ming‐Chung Wang is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Immunology, having authored 47 papers that have together received 584 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (5 papers), Eosinophilic Disorders and Syndromes (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hepatology (194 citations), Hematology (124 citations), Epidemiology (218 citations), Oncology (164 citations) and Genetics (63 citations). Ming‐Chung Wang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Ching‐Yuan Kuo, Ming‐Chun Ma, Sung‐Nan Pei, Chien‐Hung Chen, Chuan–Mo Lee, Tsung‐Hui Hu, Wan‐Ting Huang, Huey‐Ling You, Chun‐Kai Liao and Chun‐Chih Chien. Their work appears in journals such as Blood, Clinical Biochemistry, Experimental and Molecular Pathology, Fluid Phase Equilibria and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.